UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies

Salter, CG; Beijer, D; Hardy, H; Barwick, KES; Bower, M; Mademan, I; De Jonghe, P; ... Crosby, AH; + view all (2018) Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies. Neurology Genetics , 4 (2) , Article e222. 10.1212/NXG.0000000000000222. Green open access

[thumbnail of Barwick_Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies_VoR.pdf]
Preview
Text
Barwick_Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies_VoR.pdf - Published Version

Download (410kB) | Preview

Abstract

OBJECTIVE: To identify the genetic cause of disease in 2 previously unreported families with forms of distal hereditary motor neuropathies (dHMNs). METHODS: The first family comprises individuals affected by dHMN type V, which lacks the cardinal clinical feature of vocal cord paralysis characteristic of dHMN-VII observed in the second family. Next-generation sequencing was performed on the proband of each family. Variants were annotated and filtered, initially focusing on genes associated with neuropathy. Candidate variants were further investigated and confirmed by dideoxy sequence analysis and cosegregation studies. Thorough patient phenotyping was completed, comprising clinical history, examination, and neurologic investigation. RESULTS: dHMNs are a heterogeneous group of peripheral motor neuron disorders characterized by length-dependent neuropathy and progressive distal limb muscle weakness and wasting. We previously reported a dominant-negative frameshift mutation located in the concluding exon of the SLC5A7 gene encoding the choline transporter (CHT), leading to protein truncation, as the likely cause of dominantly-inherited dHMN-VII in an extended UK family. In this study, our genetic studies identified distinct heterozygous frameshift mutations located in the last coding exon of SLC5A7, predicted to result in the truncation of the CHT C-terminus, as the likely cause of the condition in each family. CONCLUSIONS: This study corroborates C-terminal CHT truncation as a cause of autosomal dominant dHMN, confirming upper limb predominating over lower limb involvement, and broadening the clinical spectrum arising from CHT malfunction.

Type: Article
Title: Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies
Open access status: An open access version is available from UCL Discovery
DOI: 10.1212/NXG.0000000000000222
Publisher version: https://doi.org/10.1212/NXG.0000000000000222
Language: English
Additional information: © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0/).
Keywords: All Genetics, All clinical neurophysiology, All Clinical Neurology, Myasthenia, Peripheral neuropathy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10076066
Downloads since deposit
78Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item